A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 (LOTUS)

被引：0
|
作者：
Pouchain, Denis [1 ]
Boussageon, Remy [1 ,2 ,3 ]
Leroux, Gerard [4 ]
机构：
[1] CNGE, Conseil Sci, Paris, France
[2] Univ Claude Bernard Lyon 1, Coll Univ Med Gen, Lyon, France
[3] Fac RTH Laennec, Lab Biometrie & Biol Evolut, UMR 5558, Lyon, France
[4] Univ Paris Est Creteil, Dept Med Gen, Paris, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2020年 / 162期
关键词：
IN-VITRO; SARS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 173
页数：2
相关论文
共 50 条
  • [21] Assessing the Clinical Improvement in Patients with COVID-19 using Lopinavir-Ritonavir: A Systematic Review
    Magadmi, Rania M.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (44A) : 448 - 459
  • [22] Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients
    Eljaaly, Khalid
    Al-Tawfiq, Jaffar A.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 38
  • [23] Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19: a randomized clinical trial
    Kaizer, Alexander M.
    Shapiro, Nathan I.
    Wild, Jessica
    Brown, Samuel M.
    Cwik, B. Jessica
    Hart, Kimberly W.
    Jones, Alan E.
    Pulia, Michael S.
    Self, Wesley H.
    Smith, Clay
    Smith, Stephanie A.
    Ng, Patrick C.
    Thompson, B. Taylor
    Rice, Todd W.
    Lindsell, Christopher J.
    Ginde, Adit A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 128 : 223 - 229
  • [24] Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
    Yaseen M. Arabi
    Anthony C. Gordon
    Lennie P. G. Derde
    Alistair D. Nichol
    Srinivas Murthy
    Farah Al Beidh
    Djillali Annane
    Lolowa Al Swaidan
    Abi Beane
    Richard Beasley
    Lindsay R. Berry
    Zahra Bhimani
    Marc J. M. Bonten
    Charlotte A. Bradbury
    Frank M. Brunkhorst
    Meredith Buxton
    Adrian Buzgau
    Allen Cheng
    Menno De Jong
    Michelle A. Detry
    Eamon J. Duffy
    Lise J. Estcourt
    Mark Fitzgerald
    Rob Fowler
    Timothy D. Girard
    Ewan C. Goligher
    Herman Goossens
    Rashan Haniffa
    Alisa M. Higgins
    Thomas E. Hills
    Christopher M. Horvat
    David T. Huang
    Andrew J. King
    Francois Lamontagne
    Patrick R. Lawler
    Roger Lewis
    Kelsey Linstrum
    Edward Litton
    Elizabeth Lorenzi
    Salim Malakouti
    Daniel F. McAuley
    Anna McGlothlin
    Shay Mcguinness
    Bryan J. McVerry
    Stephanie K. Montgomery
    Susan C. Morpeth
    Paul R. Mouncey
    Katrina Orr
    Rachael Parke
    Jane C. Parker
    Intensive Care Medicine, 2021, 47 : 867 - 886
  • [25] Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
    Patel, Tejas K.
    Patel, Parvati B.
    Barvaliya, Manish
    Saurabh, Manoj Kumar
    Bhalla, Hira Lal
    Khosla, Prem Parkash
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (06) : 740 - 748
  • [26] COVID-19 treatment with lopinavir-ritonavir resulting in sick sinus syndrome: a case report
    Wang, Laureen Yi-Ting
    Ng, Gavin Yeow Ping
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2020, 4 (FI1) : 1 - 6
  • [27] Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment
    Osborne, Vicki
    Davies, Miranda
    Lane, Samantha
    Evans, Alison
    Denyer, Jacqueline
    Dhanda, Sandeep
    Roy, Debabrata
    Shakir, Saad
    DRUG SAFETY, 2020, 43 (08) : 809 - 821
  • [28] Lopinavir-Ritonavir Treatment for COVID-19 Infection in Intensive Care Unit Risk of Bradycardia
    Beyls, Christophe
    Martin, Nicolas
    Hermida, Alexis
    Abou-Arab, Osama
    Mahjoub, Yazine
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2020, 13 (08): : E008798
  • [29] Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
    Russo, Vincenzo
    Carbone, Andreina
    Mottola, Filiberto Fausto
    Mocerino, Rosa
    Verde, Raffaele
    Attena, Emilio
    Verde, Nicoletta
    Di Micco, Pierpaolo
    Nunziata, Luigi
    Santelli, Francesco
    Nigro, Gerardo
    Severino, Sergio
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [30] Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
    Horby, Peter W.
    Landray, Martin J.
    Mafham, Marion
    Bell, Jennifer L.
    Linsell, Louise
    Staplin, Natalie
    Emberson, Jonathan R.
    Palfreeman, Adrian
    Raw, Jason
    Elmahi, Einas
    Prudon, Benjamin
    Green, Christopher
    Carley, Simon
    Chadwick, David
    Davies, Matthew
    Wise, Matthew P.
    Baillie, J. Kenneth
    Chappell, Lucy C.
    Faust, Saul N.
    Jaki, Thomas
    Jeffery, Katie
    Lim, Wei Shen
    Montgomery, Alan
    Rowan, Kathryn
    Juszczak, Edmund
    Haynes, Richard
    LANCET, 2020, 396 (10259): : 1345 - 1352
12345